AU769262B2 - A interleukin-1 receptor antagonist and uses thereof - Google Patents

A interleukin-1 receptor antagonist and uses thereof Download PDF

Info

Publication number
AU769262B2
AU769262B2 AU34495/99A AU3449599A AU769262B2 AU 769262 B2 AU769262 B2 AU 769262B2 AU 34495/99 A AU34495/99 A AU 34495/99A AU 3449599 A AU3449599 A AU 3449599A AU 769262 B2 AU769262 B2 AU 769262B2
Authority
AU
Australia
Prior art keywords
seq
polypeptide
polynucleotide
protein
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34495/99A
Other languages
English (en)
Other versions
AU3449599A (en
Inventor
John Ford
Ann Pace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arca Biopharma Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of AU3449599A publication Critical patent/AU3449599A/en
Assigned to NUVELO, INC. reassignment NUVELO, INC. Amend patent request/document other than specification (104) Assignors: HYSEQ, INC.
Application granted granted Critical
Publication of AU769262B2 publication Critical patent/AU769262B2/en
Assigned to ARCA BIOPHARMA, INC. reassignment ARCA BIOPHARMA, INC. Request to Amend Deed and Register Assignors: NUVELO, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34495/99A 1998-04-03 1999-04-05 A interleukin-1 receptor antagonist and uses thereof Ceased AU769262B2 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US5501098A 1998-04-03 1998-04-03
US09/055010 1998-04-03
US7990998A 1998-05-15 1998-05-15
US09/079909 1998-05-15
US8236498A 1998-05-20 1998-05-20
US09/082364 1998-05-20
US9981898A 1998-06-19 1998-06-19
US09/099818 1998-06-19
US12769898A 1998-07-31 1998-07-31
US09/127698 1998-07-31
US22959199A 1999-01-13 1999-01-13
US09/229591 1999-01-13
US25137099A 1999-02-17 1999-02-17
US09/251370 1999-02-17
PCT/US1999/004291 WO1999051744A2 (fr) 1998-04-03 1999-04-05 Antagoniste du recepteur de l'interleukine-1 et ses utilisations

Publications (2)

Publication Number Publication Date
AU3449599A AU3449599A (en) 1999-10-25
AU769262B2 true AU769262B2 (en) 2004-01-22

Family

ID=27568093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34495/99A Ceased AU769262B2 (en) 1998-04-03 1999-04-05 A interleukin-1 receptor antagonist and uses thereof

Country Status (6)

Country Link
EP (1) EP1068321A2 (fr)
JP (1) JP2002510492A (fr)
AU (1) AU769262B2 (fr)
CA (1) CA2326066A1 (fr)
IL (1) IL138576A0 (fr)
WO (1) WO1999051744A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ505881A (en) 1998-01-09 2003-05-30 Immunex Corp IL-1 delta DNA and polypeptides
US6541623B1 (en) * 1998-04-03 2003-04-01 Hyseq, Inc. Interleukin—1 receptor antagonist and uses thereof
AU6296899A (en) * 1998-10-08 2000-04-26 Zymogenetics Inc. Interleukin-1 homolog
JP5456222B2 (ja) 1998-12-23 2014-03-26 ジェネンテック， インコーポレイテッド Ｉｌ−１関連ポリペプチド
US6339141B1 (en) 1999-05-20 2002-01-15 Hycey Inc. Interleukin-1 Hy2 materials and methods
AU5282600A (en) * 1999-05-20 2000-12-12 Hyseq, Inc. Interleukin-1 hy2 materials and methods
US6627199B1 (en) 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
JP2003523943A (ja) * 1999-07-16 2003-08-12 インターリューキン ジェネティックス インコーポレイテッド Ｉｌ−１ｌ１遺伝子およびポリペプチド生成物
AU6517800A (en) 1999-08-04 2001-03-05 Amgen, Inc. Ntr3, a member of the tnf-receptor supergene family
US6521422B1 (en) 1999-08-04 2003-02-18 Amgen Inc. Fhm, a novel member of the TNF ligand supergene family
WO2001089549A2 (fr) * 2000-05-22 2001-11-29 Hyseq, Inc. Utilisations therapeutiques d'antagoniste du recepteur de l'il-1
US20030099650A1 (en) * 2001-07-25 2003-05-29 Ho Alice Suk-Yue Treatment of immune disorders and B cell disorders
AU2005220156B2 (en) * 2004-02-27 2011-06-02 Vaxconsulting Peptides of IL1 beta and TNF alpha and method of treatment using same
US8323635B2 (en) 2007-11-14 2012-12-04 General Regeneratives, Ltd. Methods of using interleukin-1 receptor antagonist as a myeloprotective agent
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
US20160000936A1 (en) 2014-06-10 2016-01-07 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017249A1 (fr) * 1990-05-01 1991-11-14 Cetus Corporation Antagoniste d'interleucine-1 et utilisation de celui-ci
WO1998047921A1 (fr) * 1997-04-21 1998-10-29 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes
WO1999035268A1 (fr) * 1998-01-09 1999-07-15 Immunex Corporation Adn codant il-1 delta et polypeptides il-1 delta

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148009B1 (ko) 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991017249A1 (fr) * 1990-05-01 1991-11-14 Cetus Corporation Antagoniste d'interleucine-1 et utilisation de celui-ci
WO1998047921A1 (fr) * 1997-04-21 1998-10-29 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes
WO1999035268A1 (fr) * 1998-01-09 1999-07-15 Immunex Corporation Adn codant il-1 delta et polypeptides il-1 delta

Also Published As

Publication number Publication date
EP1068321A2 (fr) 2001-01-17
AU3449599A (en) 1999-10-25
WO1999051744A3 (fr) 2000-03-30
IL138576A0 (en) 2001-10-31
JP2002510492A (ja) 2002-04-09
CA2326066A1 (fr) 1999-10-14
WO1999051744A2 (fr) 1999-10-14

Similar Documents

Publication Publication Date Title
US6337072B1 (en) Interleukin-1 receptor antagonist and recombinant production thereof
US6339141B1 (en) Interleukin-1 Hy2 materials and methods
AU769262B2 (en) A interleukin-1 receptor antagonist and uses thereof
US6541623B1 (en) Interleukin—1 receptor antagonist and uses thereof
EP1179068B1 (fr) Substances liees a l'interleukine-1 hy2 (il-1 hy2) et procedes
US6884872B1 (en) Methods and compositions relating to CD39-like polypeptides and nucleic acids
US6294655B1 (en) Anti-interleukin-1 receptor antagonist antibodies and uses thereof
US6392018B1 (en) EGF MOTIF protein obtained from a cDNA library of fetal liver-spleen
US6426191B1 (en) Assays involving an IL-1 receptor antagonist
US6392019B1 (en) Antibodies specific for EGF motif proteins
US20020156009A1 (en) Novel interleukin - 1 Hy2 materials and methods
US20040059098A1 (en) Egf motif protein, egfl6 materials and methods
US6800443B2 (en) Method of detecting a cancerous cell expressing an EGF motif polynucleotide
US6899875B1 (en) Methods and compositions relating to CD39-like polypeptides and nucleic acids
WO1999032631A1 (fr) CHIMIOKINE OBTENUE A PARTIR D'UNE BANQUE D'ADNc DE FOIE-RATE DE FOETUS
US20020107386A1 (en) Methods and compositions relating to bone-derived growth factor-like polypeptides
US20020081625A1 (en) Member of the immunoglobulin superfamily and uses thereof
EP1114159A1 (fr) Procedes et compositions se rapportant aux polypeptides contenant des repetitions d'egf
WO2000073320A1 (fr) CHIMIOKINE PROVENANT D'UNE LIBRAIRIE D'ADNc DE TISSU FOETAL HEPATO-SPLENIQUE
WO1999045117A2 (fr) Interferon ien-hy et leurs utilisations
MXPA00009515A (en) A interleukin-1 receptor antagonist and uses thereof

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: NUVELO, INC.

Free format text: FORMER NAME: HYSEQ, INC.

FGA Letters patent sealed or granted (standard patent)